CARA VALENTI: Open Payments
NPI 1902532674 · CHESHIRE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 21 payments from 5 companies in 2025. Trend: 2023 $899 · 2024 $765 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $278 |
| Novo Nordisk Inc | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Antares Pharma, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: QULIPTA, UBRELVY, SHINGRIX, XYOSTED, FARXIGA, VRAYLAR.
Industry payments across CT — which companies pay providers there.
